Aneuploidy
|
Increasing
|
133,120
|
Bak
|
Highly expressed in carcinoids
|
126
|
Bax
|
Decreasing
|
23,112,124
|
Bcl-2
|
Increasing (decrease in metastatic SCLCs)
|
23,112,124
|
BCL-X
|
Expressed in TCs
|
127
|
c-ets-1
|
Highly expressed in high-grade NE tumors
|
179
|
CD44S
|
Decreasing
|
100
|
CD44v6
|
Its loss is associated with aggressivity
|
100
|
CD99
|
Expressed only in TCs
|
102–104
|
Ki-67 labeling
|
Increasing
|
114,193,194
|
MCL-1
|
Highly expressed in carcinoids
|
126
|
PAI-1
|
Increasing
|
188
|
PAI-2
|
Decreasing
|
188
|
p53
|
Increasing
|
60,100,126
|
Rb
|
Decreasing
|
11,38,58,134,135, 143–145,148–152
|
Topo II α
|
Increasing (although there are no reports for LCLCs)
|
254,263,266
|
u-PA
|
Increasing
|
187,188
|